Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 2 | 2023 | 24 | 1.550 |
Why?
|
| Nose Neoplasms | 2 | 2017 | 17 | 1.110 |
Why?
|
| Mouth Neoplasms | 1 | 2022 | 31 | 0.810 |
Why?
|
| Head and Neck Neoplasms | 2 | 2024 | 153 | 0.780 |
Why?
|
| Skull Base | 1 | 2021 | 13 | 0.750 |
Why?
|
| Neck | 1 | 2020 | 46 | 0.700 |
Why?
|
| Preoperative Care | 1 | 2021 | 174 | 0.690 |
Why?
|
| Head | 1 | 2020 | 52 | 0.690 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 96 | 0.620 |
Why?
|
| Software | 1 | 2021 | 367 | 0.600 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 15 | 0.590 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2017 | 2 | 0.590 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 636 | 0.580 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 450 | 0.520 |
Why?
|
| Algorithms | 1 | 2021 | 986 | 0.510 |
Why?
|
| Internship and Residency | 1 | 2023 | 722 | 0.500 |
Why?
|
| Melanoma | 1 | 2016 | 334 | 0.420 |
Why?
|
| Paranasal Sinuses | 2 | 2021 | 7 | 0.360 |
Why?
|
| Endoscopy | 2 | 2021 | 97 | 0.320 |
Why?
|
| Sinusitis | 2 | 2019 | 27 | 0.300 |
Why?
|
| Humans | 16 | 2024 | 59302 | 0.240 |
Why?
|
| Free Tissue Flaps | 1 | 2024 | 2 | 0.240 |
Why?
|
| Osteoradionecrosis | 1 | 2024 | 3 | 0.240 |
Why?
|
| Male | 11 | 2024 | 27481 | 0.230 |
Why?
|
| Female | 11 | 2024 | 30799 | 0.210 |
Why?
|
| Salvage Therapy | 1 | 2022 | 73 | 0.200 |
Why?
|
| Adolescent | 4 | 2021 | 5914 | 0.190 |
Why?
|
| Survival Rate | 3 | 2018 | 787 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 91 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 301 | 0.180 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 30 | 0.180 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 304 | 0.170 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2018 | 61 | 0.170 |
Why?
|
| Robotics | 1 | 2020 | 48 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 15729 | 0.170 |
Why?
|
| Young Adult | 2 | 2021 | 4318 | 0.170 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5141 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2024 | 5967 | 0.160 |
Why?
|
| Nasal Polyps | 1 | 2019 | 8 | 0.160 |
Why?
|
| Middle Aged | 8 | 2024 | 16232 | 0.160 |
Why?
|
| Doxycycline | 1 | 2019 | 41 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5063 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2461 | 0.150 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2017 | 3 | 0.150 |
Why?
|
| Aged | 6 | 2024 | 13285 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 19 | 0.150 |
Why?
|
| Tampons, Surgical | 1 | 2017 | 1 | 0.150 |
Why?
|
| Nasal Cavity | 1 | 2017 | 10 | 0.150 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 57 | 0.150 |
Why?
|
| Meningioma | 1 | 2018 | 58 | 0.150 |
Why?
|
| Rhinitis | 1 | 2017 | 22 | 0.140 |
Why?
|
| Pharynx | 1 | 2017 | 21 | 0.140 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2017 | 5 | 0.140 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 17 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 102 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2017 | 837 | 0.140 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2016 | 2 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1127 | 0.130 |
Why?
|
| Carcinoma | 1 | 2016 | 117 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2016 | 553 | 0.120 |
Why?
|
| Thrombopoiesis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2017 | 408 | 0.110 |
Why?
|
| United States | 3 | 2023 | 7492 | 0.110 |
Why?
|
| Erythropoiesis | 1 | 2014 | 35 | 0.110 |
Why?
|
| Prognosis | 1 | 2017 | 1564 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 152 | 0.100 |
Why?
|
| Child | 1 | 2020 | 4298 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1019 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1189 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 354 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2019 | 731 | 0.060 |
Why?
|
| Microsurgery | 1 | 2024 | 52 | 0.060 |
Why?
|
| Cadaver | 1 | 2021 | 102 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2019 | 30 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 345 | 0.040 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2017 | 15 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 44 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 434 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2019 | 684 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 387 | 0.030 |
Why?
|
| Nausea | 1 | 2017 | 109 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 47 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 127 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 781 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1454 | 0.030 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2014 | 1 | 0.030 |
Why?
|
| Erythroblasts | 1 | 2014 | 15 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2014 | 20 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1447 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 171 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 101 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 336 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 424 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 250 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 659 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 589 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3186 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1456 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 10253 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 19607 | 0.010 |
Why?
|